- Home
- NBY vs EML Comparison
NBY vs EML Comparison
Compare NBY & EML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- EML
- Stock Information
- Founded
- NBY 2000
- EML 1858
- Country
- NBY United States
- EML United States
- Employees
- NBY N/A
- EML N/A
- Industry
- NBY
- EML Industrial Machinery/Components
- Sector
- NBY
- EML Consumer Discretionary
- Exchange
- NBY Nasdaq
- EML Nasdaq
- Market Cap
- NBY 3.5M
- EML 141.7M
- IPO Year
- NBY 2007
- EML N/A
- Fundamental
- Price
- NBY $0.63
- EML $23.70
- Analyst Decision
- NBY Strong Buy
- EML
- Analyst Count
- NBY 1
- EML 0
- Target Price
- NBY $0.85
- EML N/A
- AVG Volume (30 Days)
- NBY 22.9K
- EML 12.4K
- Earning Date
- NBY 08-12-2025
- EML 08-05-2025
- Dividend Yield
- NBY N/A
- EML 1.86%
- EPS Growth
- NBY N/A
- EML N/A
- EPS
- NBY 0.57
- EML N/A
- Revenue
- NBY $9,781,000.00
- EML $271,440,503.00
- Revenue This Year
- NBY $23.91
- EML $1.56
- Revenue Next Year
- NBY $32.05
- EML $7.00
- P/E Ratio
- NBY $1.38
- EML $11.29
- Revenue Growth
- NBY 20.52
- EML 8.15
- 52 Week Low
- NBY $0.36
- EML $19.06
- 52 Week High
- NBY $2.45
- EML $35.03
- Technical
- Relative Strength Index (RSI)
- NBY 51.63
- EML 56.10
- Support Level
- NBY $0.58
- EML $21.78
- Resistance Level
- NBY $0.64
- EML $23.83
- Average True Range (ATR)
- NBY 0.03
- EML 0.58
- MACD
- NBY 0.00
- EML 0.02
- Stochastic Oscillator
- NBY 42.86
- EML 93.66
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
About EML Eastern Company (The)
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.